Global Biopharmaceutical Cold Chain Logistics Services Market Growth (Status and Outlook) 2026-2032
Description
The global Biopharmaceutical Cold Chain Logistics Services market size is predicted to grow from US$ 18940 million in 2025 to US$ 34350 million in 2032; it is expected to grow at a CAGR of 9.0% from 2026 to 2032.
Biopharmaceutical Cold Chain Logistics Services are specialized logistics solutions that ensure the safe storage, handling, and transportation of temperature-sensitive biopharmaceutical products, including vaccines, biologics, cell and gene therapies, and specialty drugs. Due to the sensitivity of these products to temperature fluctuations, cold chain logistics providers use precise temperature control technologies and monitoring systems to maintain the necessary conditions throughout the supply chain, ensuring product efficacy and safety upon delivery.
United States market for Biopharmaceutical Cold Chain Logistics Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Biopharmaceutical Cold Chain Logistics Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Biopharmaceutical Cold Chain Logistics Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Biopharmaceutical Cold Chain Logistics Services players cover UPS, DHL, BioLife Solutions, OOCL Logistics, FedEx, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Biopharmaceutical Cold Chain Logistics Services Industry Forecast” looks at past sales and reviews total world Biopharmaceutical Cold Chain Logistics Services sales in 2025, providing a comprehensive analysis by region and market sector of projected Biopharmaceutical Cold Chain Logistics Services sales for 2026 through 2032. With Biopharmaceutical Cold Chain Logistics Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biopharmaceutical Cold Chain Logistics Services industry.
This Insight Report provides a comprehensive analysis of the global Biopharmaceutical Cold Chain Logistics Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biopharmaceutical Cold Chain Logistics Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biopharmaceutical Cold Chain Logistics Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biopharmaceutical Cold Chain Logistics Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biopharmaceutical Cold Chain Logistics Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Biopharmaceutical Cold Chain Logistics Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
Transportation
Warehousing
Packaging
Other
Segmentation by Application:
Vaccines
Cell Therapy
Recombinant Proteins
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
UPS
DHL
BioLife Solutions
OOCL Logistics
FedEx
World Courier
Kuehne + Nagel
C.H. Robinson
DSV
Nippon Express
Kerry Logistics
AIT Worldwide Logistics
Shengsheng Pharmaceutical Cold Chain
Air Canada Cargo
SF Express
Jointown Pharmaceutical Group
Please note: The report will take approximately 2 business days to prepare and deliver.
Biopharmaceutical Cold Chain Logistics Services are specialized logistics solutions that ensure the safe storage, handling, and transportation of temperature-sensitive biopharmaceutical products, including vaccines, biologics, cell and gene therapies, and specialty drugs. Due to the sensitivity of these products to temperature fluctuations, cold chain logistics providers use precise temperature control technologies and monitoring systems to maintain the necessary conditions throughout the supply chain, ensuring product efficacy and safety upon delivery.
United States market for Biopharmaceutical Cold Chain Logistics Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Biopharmaceutical Cold Chain Logistics Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Biopharmaceutical Cold Chain Logistics Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Biopharmaceutical Cold Chain Logistics Services players cover UPS, DHL, BioLife Solutions, OOCL Logistics, FedEx, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Biopharmaceutical Cold Chain Logistics Services Industry Forecast” looks at past sales and reviews total world Biopharmaceutical Cold Chain Logistics Services sales in 2025, providing a comprehensive analysis by region and market sector of projected Biopharmaceutical Cold Chain Logistics Services sales for 2026 through 2032. With Biopharmaceutical Cold Chain Logistics Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biopharmaceutical Cold Chain Logistics Services industry.
This Insight Report provides a comprehensive analysis of the global Biopharmaceutical Cold Chain Logistics Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biopharmaceutical Cold Chain Logistics Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biopharmaceutical Cold Chain Logistics Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biopharmaceutical Cold Chain Logistics Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biopharmaceutical Cold Chain Logistics Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Biopharmaceutical Cold Chain Logistics Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
Transportation
Warehousing
Packaging
Other
Segmentation by Application:
Vaccines
Cell Therapy
Recombinant Proteins
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
UPS
DHL
BioLife Solutions
OOCL Logistics
FedEx
World Courier
Kuehne + Nagel
C.H. Robinson
DSV
Nippon Express
Kerry Logistics
AIT Worldwide Logistics
Shengsheng Pharmaceutical Cold Chain
Air Canada Cargo
SF Express
Jointown Pharmaceutical Group
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
136 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Biopharmaceutical Cold Chain Logistics Services Market Size by Player
- 4 Biopharmaceutical Cold Chain Logistics Services by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Biopharmaceutical Cold Chain Logistics Services Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


